Atika Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-59,000
Closed -$3.28M 92
2019
Q1
$3.28M Sell
59,000
-18,000
-23% -$1.1M 0.67% 56
2018
Q4
$3.82M Sell
77,000
-56,000
-42% -$3.43M 1.12% 37
2018
Q3
$11.5M Buy
133,000
+54,000
+68% +$3.85M 2.06% 10
2018
Q2
$4.59M Buy
+79,000
New +$3.86M 0.88% 44

Other funds holding TDOC

Atika Capital Management's TDOC Position: Q2 2019 in Review

Atika Capital Management sold out of Teladoc Health (TDOC) in Q2 2019, closing a stake of 59,000 shares — an estimated $3.28M sold.

Atika Capital Management first reported a position in TDOC in Q2 2018 and held it in 4 quarters. The position peaked at $11.5M in Q3 2018. 371 funds tracked by Wall St. Rank hold TDOC as of Q2 2019.

  • Atika Capital Management reported no remaining Teladoc Health position as of Q2 2019 after selling out during the quarter.
  • Atika Capital Management sold 59,000 Teladoc Health shares in Q2 2019, an estimated $3.28M.
  • Atika Capital Management first reported a position in Teladoc Health in Q2 2018 and held it in 4 quarters.
  • Atika Capital Management's Teladoc Health position peaked at $11.5M in Q3 2018.
  • 371 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2019.

Based on Atika Capital Management's 13F filing for Q2 2019, filed 12 Aug 2019.